Exchange Traded Concepts’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,663
| Closed | -$140K | – | 1261 |
|
|
2022
Q4 | $140K | Buy |
3,663
+914
| +33% | +$34.9K | ﹤0.01% | 736 |
|
|
2022
Q3 | $108K | Buy |
2,749
+346
| +14% | +$13.6K | ﹤0.01% | 740 |
|
|
2022
Q2 | $78K | Buy |
2,403
+1,555
| +183% | +$50.5K | ﹤0.01% | 827 |
|
|
2022
Q1 | $28K | Buy |
+848
| New | +$28K | ﹤0.01% | 997 |
|
|
2021
Q3 | – | Sell |
-285
| Closed | -$16K | – | 1214 |
|
|
2021
Q2 | $16K | Buy |
+285
| New | +$16K | ﹤0.01% | 1000 |
|
|
2021
Q1 | – | Sell |
-8,539
| Closed | -$739K | – | 1144 |
|
|
2020
Q4 | $739K | Buy |
+8,539
| New | +$739K | 0.03% | 271 |
|